BTMD insider trading

NasdaqGM Healthcare

biote Corp. — scored insider trade history from SEC Form 4 filings, parsed and contextualised by FilingIQ.

Total Form 4 trades
93
Last 90 days
15
Buys / sells
31% / 6%
Market cap
$70.13M

About biote Corp.

biote Corp. operates in practice-building business within the hormone optimization space. It trains physicians and nurse practitioners in hormone optimization using bioidentical hormone replacement pellet therapy in men and women experiencing hormonal imbalance. The company offers Biote Method, a comprehensive end-to-end practice building platform that provides Biote-certified practitioners with the components developed for practitioners in the hormone optimization space comprising Biote Method education, training, and certification; practice management software that allows Biote-certified practitioners to order, track, and manage hormone optimization product inventory and meet other administrative requirements; inventory management software to facilitate ordering and inventory control; and information regarding available hormone replacement therapy products, as well as digital and point-of-care marketing support. It also sells dietary supplements under the Biote brand; and sterile pellet insertion kits that is used with hormone optimization therapies for male and female patients. The company was founded in 2012 and is headquartered in Irving, Texas.

Company website: www.biote.com

BTMD insider activity at a glance

FilingIQ has scored 93 insider transactions for BTMD since May 26, 2022. The most recent filing in our index is dated May 12, 2026.

Across the full history, 29 open-market purchases and 6 open-market sales were filed under transaction codes P and S respectively. Compensatory share awards (code A) and option exercises (code M) are tracked separately and not counted here.

The average FilingIQ composite score on BTMD insider trades is 57.6/100, produced by FilingIQ's multi-factor Form 4 model. Model framework documented at methodology.

Latest BTMD Form 4 filings

Most recent disclosures. Sign up to filter by score, transaction code, or insider role.

Other Healthcare tickers with recent insider activity

Frequently asked

How many insider trades does FilingIQ track for BTMD?
FilingIQ tracks 93 Form 4 insider transactions for BTMD (biote Corp.), covering filings from May 26, 2022 onwards. 15 of those were filed in the last 90 days.
Are BTMD insiders net buyers or net sellers?
Across the full Form 4 history for BTMD, 29 transactions (31%) were open-market purchases and 6 (6%) were open-market sales. Compensatory awards and option exercises are filtered out of these counts.
Where does BTMD insider data come from?
Every transaction shown on this page is sourced directly from SEC EDGAR Form 4 filings. FilingIQ parses the raw XML, normalises insider identity across reporting variations, and scores each trade on its multi-factor composite model.
What sector is BTMD in?
biote Corp. (BTMD) is classified in the Healthcare sector, specifically Medical Care Facilities, with a current market capitalisation of $70.13M.

Methodology & sources

Every BTMD insider transaction shown on FilingIQ is parsed directly from a public SEC Form 4 XML filing. Insider identity is normalised across reporting variants (CIK changes, name spellings, related-party indirect holdings). The FilingIQ composite score is documented in full on the team page and algo disclosure. Not investment advice; see disclaimer.